SSX2 and undifferentiated (embryonal) sarcoma: Gene rearrangements can lead to SSX2 fusion genes such as SS18-SSX2, a main oncogenic driver and diagnostic marker in synovial sarcoma, and the more recently identified EWSR1-SSX2 fusion gene in a patient with undifferentiated sarcoma of the bone.193